InvestSMART

IperionX Limited (ASX: IPX) - Announcements

Current share price for IPX : $3.270 0.19 (5.49%)+

ASX company news and announcements for IperionX Limited (IPX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All IperionX Limited (IPX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than IperionX Limited (IPX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for IperionX Limited (IPX)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$1,183 Application for quotation of securities - IPX 17 Nov 2023 3:59PM $1.480 $3.265 risen by 120.61%
$1,183 Change in substantial holding 16 Nov 2023 6:41PM $1.500 $3.265 risen by 117.67%
$1,183 Change in substantial holding 16 Nov 2023 8:20AM $1.490 $3.265 risen by 119.13%
$1,183 Change of Director's Interest Notice 13 Nov 2023 5:33PM $1.510 $3.265 risen by 116.23%
$1,183 Change of Director's Interest Notice x3 7 Nov 2023 2:55PM $1.460 $3.265 risen by 123.63%
$1,183 Notice under Section 708A 6 Nov 2023 9:56AM $1.370 $3.265 risen by 138.32%
$1,183 Application for quotation of securities - IPX 6 Nov 2023 9:53AM $1.370 $3.265 risen by 138.32%
$1,183 Application for quotation of securities - IPX 6 Nov 2023 9:49AM $1.370 $3.265 risen by 138.32%
$1,183 Notification regarding unquoted securities - IPX 6 Nov 2023 9:47AM $1.370 $3.265 risen by 138.32%
$1,183 Application for quotation of securities - IPX 6 Nov 2023 9:43AM $1.370 $3.265 risen by 138.32%
$1,183 Proposed issue of securities - IPX 1 Nov 2023 9:43AM $1.250 $3.265 risen by 161.20%
$1,183 IperionX Completes US$16.7M Placement 1 Nov 2023 9:43AM $1.250 $3.265 risen by 161.20%
$1,183 IperionX Receives US$12.7M U.S. Department of Defense Grant 1 Nov 2023 9:42AM $1.250 $3.265 risen by 161.20%
$1,183 September 2023 Quarterly Report 31 Oct 2023 12:57PM $1.250 $3.265 risen by 161.20%
$1,183 Trading Halt 30 Oct 2023 9:38AM $1.250 $3.265 risen by 161.20%
$1,183 IperionX Receives US$11.5 Million LOI From EXIM Bank 19 Oct 2023 9:01AM $1.325 $3.265 risen by 146.42%
$1,183 Notice of Annual General Meeting/Proxy Form 17 Oct 2023 2:47PM $1.315 $3.265 risen by 148.29%
$1,183 Release of Escrow Securities 12 Oct 2023 6:21PM $1.340 $3.265 risen by 143.66%
$1,183 Corporate Presentation 9 Oct 2023 8:56AM $1.300 $3.265 risen by 151.15%
$1,183 GKN Aerospace and IperionX to Advance Sustainable Titanium 2 Oct 2023 9:21AM $1.500 $3.265 risen by 117.67%
$1,183 Date of Annual General Meeting 21 Sep 2023 3:16PM $1.450 $3.265 risen by 125.17%
$1,183 Appendix 4G and Corporate Governance Statement 18 Sep 2023 6:40PM $1.525 $3.265 risen by 114.10%
$1,183 U.S. Annual Report (Form 20-F) 18 Sep 2023 6:21PM $1.525 $3.265 risen by 114.10%
$1,183 Annual Report to shareholders 18 Sep 2023 5:57PM $1.525 $3.265 risen by 114.10%
$1,183 IperionX to Produce Titanium Plate for U.S. Army Testing 7 Sep 2023 8:59AM $1.205 $3.265 risen by 170.95%

276 - 300 of 465 results

Page 12 of 19

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.